cerebralpalsyuls.net

BOTOX® (onabotulinumtoxinA), produced by Allergan, Inc., a subsidiary of AbbVie, is a medically-approved treatment specifically designed to alleviate muscle stiffness associated with spasticity in individuals aged 2 and older. It works by strategically injecting the solution into targeted muscles, thereby providing a different approach to managing spasticity compared to oral medications. Clinical studies have demonstrated its effectiveness in significantly reducing muscle stiffness in both upper and lower limbs.

BOTOX® has gained FDA approval for the treatment of adult upper limb spasticity since 2010 and is covered by most insurance plans, making it accessible to a broad range of patients. Additionally, the company offers a savings program to assist those facing financial challenges. The BOTOX® platform also provides resources to help patients locate specialists for their treatment, understand the side effects, and engage with care teams. Trusted and effective, BOTOX® is a vital option for those managing spasticity.